The Cardiovascular Risk Evaluation in People with Type 2 Diabetes on Insulin Therapy (CREDIT) registry of 3031 patients who recently started insulin therapy in Northern America, Europe, and Asia found that the mean duration of T2DM was 11 years and the mean A1c level at baseline was 9.5%.21 The gene discussed is INS; the disease is type 2 diabetes mellitus.